A detailed history of Frazier Financial Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 630 shares of MRK stock, worth $62,918. This represents 0.06% of its overall portfolio holdings.

Number of Shares
630
Previous 802 21.45%
Holding current value
$62,918
Previous $99.3 Million 27.94%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$111.15 - $128.97 $19,117 - $22,182
-172 Reduced 21.45%
630 $71.5 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $9,161 - $9,839
74 Added 10.16%
802 $99.3 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $13,135 - $15,306
116 Added 18.95%
728 $96.1 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $61,310 - $66,720
612 New
612 $66.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.